Evidence map›Paper›PMID 36932380›Full record

ArticleBMC pulmonary medicine2023

An autopsy case of disseminated Cunninghamella bertholletiae infection in an immunocompetent patient: a case report.

Masanori Harada, Kazuyo Yasuda, Kazumi Uruchida, Ryoma Yamashita, Keisuke Morikawa, Yutaro Ito, Eisuke Mochizuki, Shun Matsuura, Masaru Tsukui, Naoki Koshimizu

Open access · goldFull text readCase Reports
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Masanori HaradaDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan. mharada@hospital.iwata.shizuoka.jp.ORCID http://orcid.org/0000-0003-1610-0682
Kazuyo YasudaDepartment of Pathology, Fujieda Municipal General Hospital, Fujieda, Japan.
Kazumi UruchidaDepartment of Bacterial Laboratory, Fujieda Municipal General Hospital, Fujieda, Japan.
Ryoma YamashitaDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Keisuke MorikawaDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Yutaro ItoDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Eisuke MochizukiDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Shun MatsuuraDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Masaru TsukuiDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Naoki KoshimizuDepartment of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan.
Fujieda Municipal General Hospital · JPIwata City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, deaths due to mucormycosis in immunocompromised hosts have increased; however, the clinical and pathological features of mucormycosis are not fully understood, especially in view of the associated high mortality and rare incidence in immunocompetent patients. CASE PRESENTATION: We have described a rare autopsy case of a 67-year-old Japanese man with chronic obstructive pulmonary disease who contracted mucormycosis. He had not been on any immunosuppressants, and his immune functions were intact. Since 3 days prior to admission to our hospital, he had experienced progressive dyspnea, productive cough, and fever. Chest computed tomography revealed pleural effusion in the left lower hemithorax and consolidation in the right lung field. Although he was administered with tazobactam-piperacillin hydrate (13.5 g/day), renal dysfunction occurred on the ninth disease day. Therefore, it was switched to cefepime (2 g/day). However, his general condition and lung-field abnormality worsened gradually. Cytological analysis of the sputum sample at admission mainly revealed sporangiophores and unicellular sporangioles, while repeated sputum culture yielded Cunninghamella species. Therefore, he was diagnosed with pulmonary mucormycosis. Liposomal amphotericin B (5 mg/kg/day) was initiated on the 28

conclusionsCunninghamella bertholletiae could rapidly progress from colonizing the bronchi to infecting the surrounding organs via vascular invasion even in immunocompetent patients.

Indexed as

Lung Diseases, FungalMucormycosisAgedAutopsyCunninghamellaHumansMaleColonizationCunninghamella bertholletiaeImmunocompetentVascular invasion

Identifiers

PMID36932380
PMCPMC10022292
OpenAlexW4327811807

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read14
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.